Nutex Health Inc.
NUTX
$90.28
-$15.06-14.30%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 875.26M | 981.20M | 792.19M | 624.28M | 479.95M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 875.26M | 981.20M | 792.19M | 624.28M | 479.95M |
| Cost of Revenue | 403.95M | 415.20M | 359.19M | 294.36M | 259.11M |
| Gross Profit | 471.31M | 565.99M | 433.00M | 329.92M | 220.83M |
| SG&A Expenses | 58.16M | 186.39M | 173.70M | 93.05M | 64.08M |
| Depreciation & Amortization | 20.53M | 20.62M | 20.59M | 19.88M | 18.97M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 482.63M | 622.21M | 553.48M | 407.29M | 342.17M |
| Operating Income | 392.63M | 358.98M | 238.70M | 216.99M | 137.78M |
| Income Before Tax | 244.78M | 327.54M | 201.02M | 181.20M | 109.83M |
| Income Tax Expenses | 64.42M | 64.29M | 41.74M | 35.04M | 15.02M |
| Earnings from Continuing Operations | 180.36 | 263.25 | 159.29 | 146.16 | 94.81 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -109.57M | -142.68M | -102.94M | -72.48M | -42.71M |
| Net Income | 70.79M | 120.57M | 56.35M | 73.68M | 52.10M |
| EBIT | 392.63M | 358.98M | 238.70M | 216.99M | 137.78M |
| EBITDA | 413.16M | 379.61M | 259.30M | 236.87M | 156.76M |
| EPS Basic | 10.74 | 20.88 | 10.88 | 13.76 | 9.94 |
| Normalized Basic EPS | 16.80 | 10.60 | 4.63 | 8.46 | 5.84 |
| EPS Diluted | 9.53 | 19.27 | 9.79 | 12.67 | 9.43 |
| Normalized Diluted EPS | 16.04 | 9.50 | 3.88 | 7.71 | 5.50 |
| Average Basic Shares Outstanding | 25.44M | 23.58M | 21.98M | 20.95M | 20.13M |
| Average Diluted Shares Outstanding | 26.94M | 25.42M | 23.34M | 22.32M | 20.47M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | 10.40% | 6.11% | 13.07% | 9.99% | 0.92% |